OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Pharmaceutical and Biomedical Analysis is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
LC-MS/MS determination of atropine toxicity: Pre-analytical effect of blood collection tube and analytical matrix	451
Metabolomic and sphingolipidomic profiling of human hepatoma cells exposed to widely used pharmaceuticals	157
Integrated cartilage metabolomics and proteomics analysis reveals the therapeutic effect of Wenjing Tongluo Decoction on Knee osteoarthritis rats	127
Characterization of the tautomeric equilibrium of molnupiravir, an antiviral for the treatment of COVID-19	125
Screening licorice for H2 receptor-binding anti-ulcer components using affinity chromatography	104
Editorial Board	89
Metabolomic and biochemical changes in the plasma and liver of toxic milk mice model of Wilson disease	70
Editorial Board	69
Study on the intervention effect of Epimedium before and after suet-oil-processed on kidney yang deficiency rats based on intestinal flora and fecal metabolomics	65
Comparative analysis of chemical components in fruits of Chebulae Fructus and its pulp based on chromatographic technology coupled with multivariate chemometric methods	60
Editorial Board	57
Detection and differentiation of active and inactive isoforms of coagulation factors II, VII, IX, and X in prothrombin complex concentrate by mass spectrometry	57
Development and validation of a ligand-binding assay for quantification of the F(ab')2 antivenom of Daboia russelii siamensis in human serum and its application to a phase I clinical study	57
Editorial Board	51
A feasible HPTLC method for concurrent quantitation of allopurinol-montelukast co-therapy in plasma and evaluation of their hepatic and renal effects in rats: Analytical, biochemical, and histopatholo	46
Qualitative and quantitative evaluations of Chuanxiong dispensing granules by using chemical fingerprint in combination with chemometrics methods	45
A preclinical study on online monitoring of exhaled ciprofol concentration by the ultraviolet time-of-flight spectrometer and prediction of anesthesia depth in beagles	44
l-Asparaginase and HCP quantification by SWATH LC-MS/MS for new and improved purification step in Erwinia chrysanthemi l-asparaginase manufacture	43
Chromatographic analysis and pKa evaluation of active pharmaceutical ingredients in anti-metastatic breast cancer: Green vs. conventional RPLC	42
A high-throughput analytical method for multiple DNA targets based on microdroplet PCR coupled with DGGE	42
Determination of famprofazone, amphetamine and methamphetamine in liver samples using enzymatic cell dispersion and SPE-LC-ESI-MS	41
Identification of ADB-5’Br-BINACA in plant material and analytical characterization using GC-MS, LC-QTOF-MS, NMR and ATR-FTIR	41
LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib	40
An efficient approach to probe bioactive components of herbal patches by 2D-carbon microfiber fractionation and multi-chamber membrane separation electrophoresis: Spatholobus suberectus Dunn as a case	40
Development and evaluation of a new test kit for determination of immunosuppressants in blood by UHPLC-MS/MS	39

Illuminating green fluorescent protein: Characterizing tri-peptide fluorescent chromophore, probing reactivity of cysteines, and unveiling site-directed modifications through mass spectrometry	39
A simplified non-reduced peptide mapping method with faster and efficient enzymatic digestion for characterization of native disulfide bonds in monoclonal and bispecific antibodies	39
Development and validation of an UPLC-MS/MS method for simultaneous determination of fifteen targeted anti-cancer drugs in human plasma and its application in therapeutic drug monitoring	39
GC and HPLC-RID method development and validation for the determination of twelve related substances, including several novel compounds in tetrabenazine	39
New insights into the chemistry and anticancer activity of Ophiocordyceps xuefengensis	38
Development of salting-out extraction methodology for the determination of piroxicam from polymeric based nanocarriers and biological samples	37
The importance of method validation in herbal drug research	37
Integrated UHPLC-MS untargeted metabolomics and gut microbe metabolism pathway-targeted metabolomics to reveal the prevention mechanism of Gushudan on kidney-yang-deficiency-syndrome rats	37
NMR-based metabolomics of dried berries in comparison with dietary supplements	36
Electrochemistry/mass spectrometry (EC/MS) for fast generation and identification of novel reactive metabolites of two unsymmetrical bisacridines with anticancer activity	36
A ratiometric electrochemical biosensor via alkaline phosphatase mediated dissolution of nano-MnO2 and Ru(III) redox recycling for the determination of dimethoate	36
An evaluation of qH NMR: A complementary approach to GC-FID for quantification of Thymol and trans-Anethole in essential oils and supplements	36